Trial intelligence / Profile preview

Tongfu Qinghua Decoction and Ruyi Jinhuang Powder in Acute Pancreatitis

NCT07712081Completed

Sponsor
Ruian People's Hospital
Start
Oct 2023
Primary completion
Aug 2025
Countries
1
01

Overview

Randomised, open-label trial of ruyi jinhuang powder in acute pancreatitis (AP) (2 arms), sponsored by Ruian People's Hospital. Primary endpoint: Overall Clinical Response Rate at 5 days. Started Oct 2023; status: completed.

02

Drugs

ruyi jinhuang powder
03

Conditions

acute pancreatitis (AP)

Beyond the preview

Go deeper on NCT07712081.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07712081.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call